Broncus Holding Corporation (HKG:2216)
Hong Kong · Delayed Price · Currency is HKD 2.260
+0.200 (9.71%)
Jul 16, 2025, 4:08 PM HKT
Broncus Holding Revenue
In the year 2024, Broncus Holding had annual revenue of $8.13M USD, down -20.71%. Broncus Holding had revenue of $4.43M in the half year ending December 31, 2024, a decrease of -28.54%.
Revenue
$8.13M
Revenue Growth
-20.71%
P/S Ratio
18.81
Revenue / Employee
$40.66K
Employees
200
Market Cap
1.19B HKD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |
| CSPC Pharmaceutical Group | 28.99B |